Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 156

    1.

    Deleterious effects of acute treatment with a peroxisome proliferator-activated receptor-gamma activator in myocardial ischemia and reperfusion in pigs.

    Xu Y, Lu L, Greyson C, Lee J, Gen M, Kinugawa K, Long CS, Schwartz GG.

    Diabetes. 2003 May;52(5):1187-94.PMID: 12716751 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Troglitazone improves recovery of left ventricular function after regional ischemia in pigs.

    Zhu P, Lu L, Xu Y, Schwartz GG.

    Circulation. 2000 Mar 14;101(10):1165-71.PMID: 10715264 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    PPAR-gamma activation fails to provide myocardial protection in ischemia and reperfusion in pigs.

    Xu Y, Gen M, Lu L, Fox J, Weiss SO, Brown RD, Perlov D, Ahmad H, Zhu P, Greyson C, Long CS, Schwartz GG.

    Am J Physiol Heart Circ Physiol. 2005 Mar;288(3):H1314-23. Epub 2004 Nov 4.PMID: 15528232 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.

    Ma LJ, Marcantoni C, Linton MF, Fazio S, Fogo AB.

    Kidney Int. 2001 May;59(5):1899-910.PMID: 11318962 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.

    Yue Tl TL, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, Lysko PG, Gu JL, Boyce R, Zimmerman DM, Hart TK, Buckingham RE, Ohlstein EH.

    Circulation. 2001 Nov 20;104(21):2588-94.PMID: 11714655 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats.

    Sakai S, Miyauchi T, Irukayama-Tomobe Y, Ogata T, Goto K, Yamaguchi I.

    Clin Sci (Lond). 2002 Aug;103 Suppl 48:16S-20S.PMID: 12193046 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.

    Cao Z, Ye P, Long C, Chen K, Li X, Wang H.

    Pharmacology. 2007;79(3):184-92. Epub 2007 Mar 14.PMID: 17356310 [PubMed - indexed for MEDLINE]Related articles

    8.

    Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.

    Camp HS, Li O, Wise SC, Hong YH, Frankowski CL, Shen X, Vanbogelen R, Leff T.

    Diabetes. 2000 Apr;49(4):539-47.PMID: 10871190 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury.

    Doi S, Masaki T, Arakawa T, Takahashi S, Kawai T, Nakashima A, Naito T, Kohno N, Yorioka N.

    Transplantation. 2007 Jul 27;84(2):207-13.PMID: 17667812 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cardioprotective effects of troglitazone in streptozotocin-induced diabetic rats.

    Shimabukuro M, Higa S, Shinzato T, Nagamine F, Komiya I, Takasu N.

    Metabolism. 1996 Sep;45(9):1168-73.PMID: 8781306 [PubMed - indexed for MEDLINE]Related articles

    11.

    Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation.

    Ellis CN, Varani J, Fisher GJ, Zeigler ME, Pershadsingh HA, Benson SC, Chi Y, Kurtz TW.

    Arch Dermatol. 2000 May;136(5):609-16.PMID: 10815854 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Unique ability of troglitazone to up-regulate peroxisome proliferator-activated receptor-gamma expression in hepatocytes.

    Davies GF, McFie PJ, Khandelwal RL, Roesler WJ.

    J Pharmacol Exp Ther. 2002 Jan;300(1):72-7.PMID: 11752099 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin II type 1 receptor genes.

    Sugawara A, Takeuchi K, Uruno A, Ikeda Y, Arima S, Sato K, Kudo M, Taniyama Y, Ito S.

    Hypertens Res. 2001 May;24(3):229-33.PMID: 11409645 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury.

    Khandoudi N, Delerive P, Berrebi-Bertrand I, Buckingham RE, Staels B, Bril A.

    Diabetes. 2002 May;51(5):1507-14.PMID: 11978649 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model.

    Ito H, Nakano A, Kinoshita M, Matsumori A.

    Lab Invest. 2003 Dec;83(12):1715-21.PMID: 14691289 [PubMed - indexed for MEDLINE]Related articles

    17.

    Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor-gamma ligand, pioglitazone, in rats.

    Naito Y, Takagi T, Uchiyama K, Handa O, Tomatsuri N, Imamoto E, Kokura S, Ichikawa H, Yoshida N, Yoshikawa T.

    Redox Rep. 2002;7(5):294-9.PMID: 12688513 [PubMed - indexed for MEDLINE]Related articles

    18.

    The PPAR-alpha activator fenofibrate fails to provide myocardial protection in ischemia and reperfusion in pigs.

    Xu Y, Lu L, Greyson C, Rizeq M, Nunley K, Wyatt B, Bristow MR, Long CS, Schwartz GG.

    Am J Physiol Heart Circ Physiol. 2006 May;290(5):H1798-807. Epub 2005 Dec 9.PMID: 16339839 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Halothane and the reperfusion injury in the intact animal model.

    Coetzee A, Moolman J.

    Anesth Analg. 1993 Apr;76(4):734-44.PMID: 8466009 [PubMed - indexed for MEDLINE]Related articles

    20.

    Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury.

    Yue TL, Bao W, Jucker BM, Gu JL, Romanic AM, Brown PJ, Cui J, Thudium DT, Boyce R, Burns-Kurtis CL, Mirabile RC, Aravindhan K, Ohlstein EH.

    Circulation. 2003 Nov 11;108(19):2393-9. Epub 2003 Oct 13.PMID: 14557369 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data